NASDAQ · QUCY
Quantum Cyber N.V.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for QUCY: Nov 13, 2026
Quantum Cyber N.V. Ordinary Shares is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.08.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Dec 2026 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Mar 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Jun 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · MarketBeat · Quiver Quantitative- RTTNews · Feb 17, 9:52 AM ESTMainz Biomed Announces $6 Mln Private Placement In Two Tranches To Fund Operations, Stock Down(RTTNews) – Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company focused on early cancer detection, announced a $6 million private placement and its strategic transactions to bolster its liquidity position and transition the business to a focus on its pancreatic canc
- MarketBeat · Dec 12, 9:51 AM EST2 Small-Cap Biotechs That Could Reward Patient InvestorsSpeculative investors and patience rarely go hand in hand. Nevertheless, if you’re looking to invest in the small-cap biotech sector, patience is a requirement. Most, if not all, of these companies are still in the clinical stage, meaning they have no commercially available drug
- RTTNews · Nov 12, 9:25 AM ESTMainz Biomed To Present Flagship Product, ColoAlert, At MEDICA 2025(RTTNews) – Mainz Biomed N.V., (MYNZ) a molecular genetics diagnostics company, specializing in the early detection of cancer, announced its upcoming participation in MEDICA 2025, one of the world's leading healthcare trade shows, taking place from November 17 to 20, 2025, in Düs
- Quiver Quantitative · Jul 23, 8:14 AM EDTMainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in GermanyMainz Biomed collaborates with CARE to enhance early colorectal cancer detection with the ColoAlert® test in Germany.
- Quiver Quantitative · Jul 15, 8:15 AM EDTMainz Biomed N.V. Announces Key Achievements and Corporate Update for First Half of 2025Mainz Biomed reports significant achievements in early cancer detection and compliance with Nasdaq listing requirements for mid-2025.
- Quiver Quantitative · Jun 25, 8:12 AM EDTMainz Biomed Secures Public Funding from ISB for Pancreatic Cancer Early Detection ProjectMainz Biomed's pancreatic cancer project receives public funding from ISB to enhance early detection diagnostics.
- RTTNews · Jun 10, 10:40 AM EDTMainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection(RTTNews) – Mainz Biomed N.V. (MYNZ), on Tuesday, announced the launch of a feasibility study as part of its PancAlert project, which is focused on developing a non-invasive blood-based screening test for the early detection of pancreatic cancer.
- Quiver Quantitative · Jun 10, 9:35 AM EDTMainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert ProjectMainz Biomed begins the feasibility phase of its PancAlert project for non-invasive pancreatic cancer detection using blood samples.
- Quiver Quantitative · May 19, 8:10 PM EDTMainz Biomed Announces Pricing of $4 Million Follow-On Offering and Warrant AmendmentsMainz Biomed announced a follow-on offering of 2 million units, raising approximately $4 million for cancer detection initiatives.
- RTTNews · May 16, 12:57 PM EDTMainz Biomed Plans Interim Readout For EAArly DETECT 2 CRC Study(RTTNews) – Mainz Biomed N.V. (MYNZ) on Friday announced plans to provide an interim readout of its ongoing eAArly DETECT 2 clinical study by the end of summer 2025.
- Quiver Quantitative · Apr 28, 8:14 AM EDTMainz Biomed N.V. Reports Q1 2025 Accomplishments and FDA Premarket Approval ProgressMainz Biomed reports Q1 2025 achievements, including a patient enrollment in CRC study and strategic partnerships for cancer detection.
- Quiver Quantitative · Apr 5, 5:05 PM EDT$MYNZ Earnings Preview: Recent $MYNZ Insider Trading, Hedge Fund Activity, and More$MYNZ ($MYNZ) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $306,000 and earnings of -$3.67 per share.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Quantum Cyber N.V. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.